Ta strona została przetłumaczona automatycznie i dokładność tłumaczenia nie jest gwarantowana. Proszę odnieść się do angielska wersja za tekst źródłowy.

Feasibility of Lower-Body EMS Combined With Resistance Training in Postmenopausal Women: A Pilot Randomized Controlled Trial (LB-EMS-Pilot)

1 czerwca 2026 zaktualizowane przez: Kyungho Kim, Seoul National University

Feasibility and Preliminary Effects of Lower-Body Electrical Muscle Stimulation Combined With Resistance Training on Body Composition, Muscle Function, Arteriosclerotic Indices, and Autonomic Function in Postmenopausal Women: A Pilot Randomized Controlled Trial

This pilot randomized controlled trial evaluates whether combining lower-body electrical muscle stimulation (EMS) with resistance training is feasible and beneficial for physically inactive postmenopausal women, who experience concurrent declines in muscle strength, body composition, arterial elasticity, and cardiac autonomic balance.

Sixteen physically inactive postmenopausal women aged 50-70 years are randomly assigned (1:1) to either (A) supervised resistance training combined with lower-body EMS (applied to 6 muscle groups: lower back, lower abdomen, glutes, quadriceps, hamstrings, and calves) or (B) supervised resistance training alone. Both groups complete twelve 50-minute sessions (consisting of a 10-minute warm-up, 30-minute main exercise, and a 10-minute cool-down) over 6 weeks (twice weekly). Assessments before and after the intervention include body composition, lower-body muscle function, arterial stiffness, and 5-minute heart rate variability.

The primary aim is to determine the feasibility of the protocol(recruitment, retention, session attendance, and intervention dose delivery) to inform a future definitive trial. Preliminary estimates of intervention effects on the measured outcomes are reported as secondary aims.

Przegląd badań

Szczegółowy opis

BACKGROUND AND RATIONALE Postmenopausal women often experience physiological declines in muscle function, body composition, and cardiovascular health. While resistance training is an established countermeasure, maximizing its efficiency and adherence remains a challenge. Applying lower-body electrical muscle stimulation (EMS) during resistance training may enhance physiological adaptations and overall training effectiveness. This study aims to evaluate the feasibility of combining lower-body EMS with resistance training in physically inactive postmenopausal women to inform the design of a future definitive trial.

STUDY DESIGN This is a pilot randomized controlled trial. Participants will be randomly assigned to either an intervention group receiving combined lower-body EMS and resistance training or a control group receiving resistance training alone. Clinical and physiological outcomes will be assessed before and after the intervention period to evaluate preliminary effects.

PRIMARY FEASIBILITY OUTCOMES

The primary objective is to evaluate the feasibility of the study protocol. Feasibility will be determined by assessing several key components, including:

Recruitment: The ability to recruit the target population within the planned timeframe.

Retention: The proportion of participants who complete the study and post-intervention assessments.

Adherence: Participant attendance and compliance with the scheduled exercise sessions.

Intervention Fidelity: The successful delivery of the exercise intensity and EMS protocol as intended.

These components will be evaluated against pre-established progression criteria to determine whether the protocol can proceed to a larger trial or requires modification.

STATISTICAL APPROACH Feasibility outcomes will be summarized primarily using descriptive statistics. For secondary physiological and clinical outcomes, appropriate statistical methods will be utilized to estimate the preliminary effects of the intervention, comparing changes between the groups while adjusting for baseline measurements. Effect sizes and confidence intervals will be calculated to provide preliminary evidence and to assist with sample size calculations for future large-scale trials.

Typ studiów

Interwencyjne

Zapisy (Szacowany)

16

Faza

  • Nie dotyczy

Kontakty i lokalizacje

Ta sekcja zawiera dane kontaktowe osób prowadzących badanie oraz informacje o tym, gdzie badanie jest przeprowadzane.

Kontakt w sprawie studiów

  • Nazwa: Kyungho Kim, MS
  • Numer telefonu: 82 + 010-3589-8202
  • E-mail: 2007kkh@gmail.com

Lokalizacje studiów

    • Seoul
      • Seoul, Seoul, Korea Południowa, 08826
        • Rekrutacyjny
        • Seoul National University
        • Kontakt:

Kryteria uczestnictwa

Badacze szukają osób, które pasują do określonego opisu, zwanego kryteriami kwalifikacyjnymi. Niektóre przykłady tych kryteriów to ogólny stan zdrowia danej osoby lub wcześniejsze leczenie.

Kryteria kwalifikacji

Wiek uprawniający do nauki

  • Dorosły
  • Starszy dorosły

Akceptuje zdrowych ochotników

Tak

Opis

Inclusion Criteria:

  • Women aged 50 to 70 years.
  • Menopause for at least 1 year with no current menstruation.
  • Physically inactive (have not participated in resistance training more than twice a week for the past 6 months)

Exclusion Criteria:

  • Currently receiving hormone replacement therapy (HRT).
  • Presence of implanted electrical medical devices.
  • Severe or uncontrolled medical conditions.
  • Any surgery within the past 6 months.
  • Acute illness with fever, infection, or active inflammation.
  • Severe peripheral arterial disease or abdominal/inguinal hernia.
  • Severe psychiatric disorders requiring medication, or current substance abuse.
  • Deemed physically or mentally unfit to participate in the exercise program by the investigator.

Plan studiów

Ta sekcja zawiera szczegółowe informacje na temat planu badania, w tym sposób zaprojektowania badania i jego pomiary.

Jak projektuje się badanie?

Szczegóły projektu

  • Główny cel: Inny
  • Przydział: Randomizowane
  • Model interwencyjny: Przydział równoległy
  • Maskowanie: Pojedynczy

Broń i interwencje

Grupa uczestników / Arm
Interwencja / Leczenie
Eksperymentalny: A Group: EMS + Resistance Training
Lower-body EMS combined with 8 machine-based resistance exercises for 6 weeks, 2 sessions per week.
Electrical muscle stimulation (85 Hz, 350 μs, cycle 11, duty approx 1:2) applied to 6 muscle groups: lower back (erector spinae), lower abdomen, glutes, quadriceps, hamstrings, and calves.
A 50-minute session consisting of a 10-minute warm-up, 30 minutes of main exercise (8 machine-based lower-body resistance exercises, 3 sets of 8-12 repetitions), and a 10-minute cool-down.
Aktywny komparator: B Group: Resistance Training
8 machine-based resistance exercises for 6 weeks, 2 sessions per week without EMS.
A 50-minute session consisting of a 10-minute warm-up, 30 minutes of main exercise (8 machine-based lower-body resistance exercises, 3 sets of 8-12 repetitions), and a 10-minute cool-down.

Co mierzy badanie?

Podstawowe miary wyniku

Miara wyniku
Opis środka
Ramy czasowe
Composite Feasibility Outcome (Recruitment, Retention, Session Attendance, and Intervention Dose Delivery)
Ramy czasowe: Baseline and Week 6

The primary outcome is the feasibility of the study protocol, assessed via recruitment rates, participant retention, session adherence, and targeted intervention delivery. These indicators will be evaluated against pre-defined progression criteria using descriptive statistics to determine whether to proceed with or modify the protocol for a future definitive trial.

Unit: Percentage

Baseline and Week 6

Miary wyników drugorzędnych

Miara wyniku
Opis środka
Ramy czasowe
Skeletal Muscle Mass Index (SMI)
Ramy czasowe: Baseline and Week 6
Appendicular skeletal muscle mass divided by height squared. Unit: kg/m².
Baseline and Week 6
Total Body Muscle Mass
Ramy czasowe: Baseline and Week 6
Total skeletal muscle mass of the whole body. Unit: kg
Baseline and Week 6
Total Leg Muscle Mass
Ramy czasowe: Baseline and Week 6
Combined left and right leg skeletal muscle mass. Unit: kg
Baseline and Week 6
Body Fat Percentage
Ramy czasowe: Baseline and Week 6
Body fat mass expressed as a percentage of total body weight. Unit: %
Baseline and Week 6
Total Body Fat Mass
Ramy czasowe: Baseline and Week 6
Absolute total body fat in kilograms. Unit: kg
Baseline and Week 6
Estimated Visceral Fat Area (eVFA)
Ramy czasowe: Baseline and Week 6
Estimated visceral fat area at the umbilical level. Unit: cm²
Baseline and Week 6
Waist Circumference
Ramy czasowe: Baseline and Week 6
Circumference measured at the level of the umbilicus. Unit: cm
Baseline and Week 6
Waist-to-Hip Ratio (WHR)
Ramy czasowe: Baseline and Week 6
Waist circumference divided by hip circumference. Unit: ratio
Baseline and Week 6
Body Mass Index (BMI)
Ramy czasowe: Baseline and Week 6
Body weight in kilograms divided by the square of height in meters. Unit: kg/m²
Baseline and Week 6
Phase Angle
Ramy czasowe: Baseline and Week 6

Whole-body bioimpedance phase angle derived from the arctangent of the reactance-to-resistance ratio. Marker of cellular membrane integrity and overall nutritional/health status.

Unit: degrees

Baseline and Week 6
Dominant Knee Extensor Peak Torque per Body Weight at 60°/s
Ramy czasowe: Baseline and Week 6

Peak concentric knee extensor torque normalized to body weight, measured at 60°/sec angular velocity on the dominant limb.

Unit: Nm/kg

Baseline and Week 6
Non-dominant Knee Extensor Peak Torque per Body Weight at 60°/s
Ramy czasowe: Baseline and Week 6

Peak concentric knee extensor torque normalized to body weight at 60°/sec on the non-dominant limb.

Unit: Nm/kg

Baseline and Week 6
Dominant Knee Flexor Peak Torque per Body Weight at 60°/s
Ramy czasowe: Baseline and Week 6

Peak concentric knee flexor (hamstring) torque normalized to body weight at 60°/sec on the dominant limb.

Unit: Nm/kg

Baseline and Week 6
Non-dominant Knee Flexor Peak Torque per Body Weight at 60°/s
Ramy czasowe: Baseline and Week 6

Peak concentric knee flexor torque normalized to body weight at 60°/sec on the non-dominant limb.

Unit: Nm/kg

Baseline and Week 6
Dominant Hamstring-to-Quadriceps (H/Q) Ratio at 60°/s
Ramy czasowe: Baseline and Week 6

Ratio of knee flexor peak torque to knee extensor peak torque at 60°/sec on the dominant limb.

Unit: ratio

Baseline and Week 6
Non-dominant Hamstring-to-Quadriceps (H/Q) Ratio at 60°/s
Ramy czasowe: Baseline and Week 6

Ratio of knee flexor peak torque to knee extensor peak torque at 60°/sec on the non-dominant limb.

Unit: ratio

Baseline and Week 6
Dominant Total Work Done by Knee Extensor per Body Weight at 180°/s
Ramy czasowe: Baseline and Week 6

Total work performed by knee extensors across the test set, normalized to body weight, at 180°/sec angular velocity on the dominant limb.

Unit: Nm/kg

Baseline and Week 6
Non-dominant Total Work Done by Knee Extensor per Body Weight at 180°/s
Ramy czasowe: Baseline and Week 6

Total work performed by knee extensors normalized to body weight at 180°/sec on the non-dominant limb.

Unit: Nm/kg

Baseline and Week 6
Dominant Total Work Done by Knee Flexor per Body Weight at 180°/s
Ramy czasowe: Baseline and Week 6

Total work performed by knee flexors normalized to body weight at 180°/sec on the dominant limb.

Unit: Nm/kg

Baseline and Week 6
Non-dominant Total Work Done by Knee Flexor per Body Weight at 180°/s
Ramy czasowe: Baseline and Week 6

Total work performed by knee flexors normalized to body weight at 180°/sec on the non-dominant limb.

Unit: Nm/kg

Baseline and Week 6
Average Brachial-Ankle Pulse Wave Velocity (baPWV)
Ramy czasowe: Baseline and Week 6

Mean of left and right brachial-ankle pulse wave velocity; primary indicator of large-artery stiffness.

Unit: cm/s

Baseline and Week 6
Highest Brachial-Ankle Pulse Wave Velocity (baPWV)
Ramy czasowe: Baseline and Week 6
The higher of left and right baPWV values, reflecting the most affected limb. Unit: cm/s
Baseline and Week 6
Brachial Systolic Blood Pressure (SBP)
Ramy czasowe: Baseline and Week 6
Brachial systolic blood pressure. Unit: mmHg
Baseline and Week 6
Brachial Diastolic Blood Pressure (DBP)
Ramy czasowe: Baseline and Week 6
Brachial diastolic blood pressure. Unit: mmHg
Baseline and Week 6
Pulse Pressure (PP)
Ramy czasowe: Baseline and Week 6
Pulse pressure calculated as systolic minus diastolic blood pressure. Unit: mmHg
Baseline and Week 6
Mean Arterial Pressure (MAP)
Ramy czasowe: Baseline and Week 6
Mean arterial pressure derived from systolic and diastolic blood pressure. Unit: mmHg
Baseline and Week 6
Average Ankle-Brachial Index (ABI)
Ramy czasowe: Baseline and Week 6
Mean of left and right ankle-brachial systolic blood pressure ratio. Unit: ratio
Baseline and Week 6
Augmentation Index (AI)
Ramy czasowe: Baseline and Week 6
Augmentation index derived from second-derivative photoplethysmography. Unit: unitless
Baseline and Week 6
Root Mean Square of Successive Differences (RMSSD)
Ramy czasowe: Baseline and Week 6

Root mean square of successive differences between adjacent normal-to-normal RR intervals.

Unit: ms

Baseline and Week 6
High-Frequency (HF) Power
Ramy czasowe: Baseline and Week 6

Spectral power in the high-frequency band (0.15-0.4 Hz); index of parasympathetic (vagal) activity.

Unit: ms²

Baseline and Week 6
Standard Deviation of NN Intervals (SDNN)
Ramy czasowe: Baseline and Week 6

Standard deviation of all normal-to-normal RR intervals; time-domain index of overall heart rate variability.

Unit: ms

Baseline and Week 6
Low-Frequency (LF) Power
Ramy czasowe: Baseline and Week 6
Spectral power in the low-frequency band (0.04-0.15 Hz). Unit: ms²
Baseline and Week 6
LF/HF Ratio
Ramy czasowe: Baseline and Week 6
Ratio of low-frequency to high-frequency spectral power. Unit: ratio
Baseline and Week 6
High-Frequency Normalized Units (HFnu)
Ramy czasowe: Baseline and Week 6
HF power expressed in normalized units = HF / (LF + HF) × 100. Unit: n.u.
Baseline and Week 6
Low-Frequency Normalized Units (LFnu)
Ramy czasowe: Baseline and Week 6
LF power expressed in normalized units = LF / (LF + HF) × 100. Unit: n.u.
Baseline and Week 6
Total Power (TP)
Ramy czasowe: Baseline and Week 6
Total spectral power up to 0.4 Hz. Unit: ms²
Baseline and Week 6
Very-Low-Frequency (VLF) Power
Ramy czasowe: Baseline and Week 6
Spectral power in the very-low-frequency band (≤0.04 Hz). Unit: ms²
Baseline and Week 6

Inne miary wyników

Miara wyniku
Opis środka
Ramy czasowe
Dominant Knee Extensor Fatigue Index at 180°/s
Ramy czasowe: Baseline and Week 6

Percentage decline in knee extensor torque across the repetition set at 180°/sec on the dominant limb.

Unit: %

Baseline and Week 6
Non-dominant Knee Extensor Fatigue Index at 180°/s
Ramy czasowe: Baseline and Week 6

Percentage decline in knee extensor torque across the repetition set at 180°/sec on the non-dominant limb.

Unit: %

Baseline and Week 6
Dominant Knee Flexor Fatigue Index at 180°/s
Ramy czasowe: Baseline and Week 6

Percentage decline in knee flexor torque across the repetition set at 180°/sec on the dominant limb.

Unit: %.

Baseline and Week 6
Non-dominant Knee Flexor Fatigue Index at 180°/s
Ramy czasowe: Baseline and Week 6

Percentage decline in knee flexor torque across the repetition set at 180°/sec on the non-dominant limb.

Unit: %

Baseline and Week 6
Bilateral Deficit of Knee Extensors at 60°/s
Ramy czasowe: Baseline and Week 6

Percentage asymmetry of knee extensor peak torque between dominant and non-dominant limbs at 60°/sec.

Unit: %

Baseline and Week 6
Bilateral Deficit of Knee Flexors at 60°/s
Ramy czasowe: Baseline and Week 6

Percentage asymmetry of knee flexor peak torque between dominant and non-dominant limbs at 60°/sec.

Unit: %

Baseline and Week 6
Dominant Total Work Done H/Q Ratio at 180°/s
Ramy czasowe: Baseline and Week 6

Ratio of knee flexor to knee extensor total work done at 180°/sec on the dominant limb.

Unit: ratio

Baseline and Week 6
Non-dominant Total Work Done H/Q Ratio at 180°/s
Ramy czasowe: Baseline and Week 6

Ratio of knee flexor to knee extensor total work done at 180°/sec on the non-dominant limb.

Unit: ratio

Baseline and Week 6
Arterial Elasticity (AE)
Ramy czasowe: Baseline and Week 6
Arterial elasticity index derived from second-derivative photoplethysmography. Unit: unitless
Baseline and Week 6
Peripheral Elasticity (PE)
Ramy czasowe: Baseline and Week 6

Peripheral elasticity index derived from second-derivative photoplethysmography.

Unit: unitless.

Baseline and Week 6

Współpracownicy i badacze

Tutaj znajdziesz osoby i organizacje zaangażowane w to badanie.

Śledczy

  • Główny śledczy: Yeon Soo Kim, MD, Prof, Seoul National University

Daty zapisu na studia

Daty te śledzą postęp w przesyłaniu rekordów badań i podsumowań wyników do ClinicalTrials.gov. Zapisy badań i zgłoszone wyniki są przeglądane przez National Library of Medicine (NLM), aby upewnić się, że spełniają określone standardy kontroli jakości, zanim zostaną opublikowane na publicznej stronie internetowej.

Główne daty studiów

Rozpoczęcie studiów (Rzeczywisty)

1 czerwca 2026

Zakończenie podstawowe (Szacowany)

1 lipca 2026

Ukończenie studiów (Szacowany)

1 sierpnia 2026

Daty rejestracji na studia

Pierwszy przesłany

1 czerwca 2026

Pierwszy przesłany, który spełnia kryteria kontroli jakości

1 czerwca 2026

Pierwszy wysłany (Rzeczywisty)

5 czerwca 2026

Aktualizacje rekordów badań

Ostatnia wysłana aktualizacja (Rzeczywisty)

5 czerwca 2026

Ostatnia przesłana aktualizacja, która spełniała kryteria kontroli jakości

1 czerwca 2026

Ostatnia weryfikacja

1 czerwca 2026

Więcej informacji

Terminy związane z tym badaniem

Plan dla danych uczestnika indywidualnego (IPD)

Planujesz udostępniać dane poszczególnych uczestników (IPD)?

NIEZDECYDOWANY

Informacje o lekach i urządzeniach, dokumenty badawcze

Bada produkt leczniczy regulowany przez amerykańską FDA

Nie

Bada produkt urządzenia regulowany przez amerykańską FDA

Nie

Te informacje zostały pobrane bezpośrednio ze strony internetowej clinicaltrials.gov bez żadnych zmian. Jeśli chcesz zmienić, usunąć lub zaktualizować dane swojego badania, skontaktuj się z register@clinicaltrials.gov. Gdy tylko zmiana zostanie wprowadzona na stronie clinicaltrials.gov, zostanie ona automatycznie zaktualizowana również na naszej stronie internetowej .

Subskrybuj